Nasal In-situ Gel of Inert Cellulose for Allergic Rhinitis http://www.doi.org/10.26538/tjnpr/v6i9.12
Main Article Content
Abstract
Allergic rhinitis is a very common disease that is treated with a variety of systemic and locally applied drugs. The advantage of nasal route of avoiding the systemic side effect of drug is outweighed by the low effectiveness of the intranasal formulations due to the rapid cleaning mechanisms of the nose. This work aims to produce nasal in-situ gel using hydroxypropyl methyl cellulose (HPMC) as the active ingredient. HPMC is an inert cellulosic material that will provide a natural barrier against the allergens and will aid in treatment and preventing the allergic rhinitis. In addition, a pH sensitive polymer (Carbopol) had been added to this formula, to provide in-situ gelling of the solution upon contact with nasal mucosa. In this work, two concentrations of HPMC (namely 0.8% and 1.6%) have been studied. All the prepared formulas were characterized by different techniques. In addition, the muco-adhesiveness, the in-vivo
retention time and the safety of the selected formula were studied. Results indicated that hydroxypropyl methyl cellulose in-situ gel can be produced with very good characteristics using 1.6% HPMC with 0.9% carbopol. The in-vitro study confirmed the moderate gelling capacity with high muco-adhesiveness. This is supported by the in-vivo retention time study which is conducted on live sheep and the recorded retention time was prolonged. The histopathology study confirmed the absence of any toxic or necrotic effect on nasal tissue. To conclude, this study succeeded in formulating a new promising, comfortable and safe treatment of allergic
rhinitis.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Small P, Keith PK, Kim H. Allergic rhinitis. Allergy, Asthma Clin Immunol [Internet]. 2018; 14(s2):1–11.
Watts AM, Cripps AW, West NP, Cox AJ. Modulation of Allergic Inflammation in the Nasal Mucosa of Allergic Rhinitis Sufferers with Topical Pharmaceutical Agents. Front Pharmacol. 2019 Mar; 29(10):294.
Brożek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, Brignardello-Petersen R, Canonica GW, Casale T, Chavannes NH, Correia de Sousa J, Cruz AA, Cuello-Garcia CA, Demoly P, Dykewicz M, EtxeandiaIkobaltzeta I, Florez ID, Fokkens W, Fonseca J, Hellings PW,
Klimek L, Kowalski S, Kuna P, Laisaar KT, LarenasLinnemann DE, Lødrup Carlsen KC, Manning PJ, Meltzer E, Mullol J, Muraro A, O'Hehir R, Ohta K, Panzner P, Papadopoulos N, Park HS, Passalacqua G, Pawankar R, Price D, Riva JJ, Roldán Y, Ryan D, Sadeghirad B, Samolinski B,
Schmid-Grendelmeier P, Sheikh A, Togias A, Valero A, Valiulis A, Valovirta E, Ventresca M, Wallace D, Waserman S, Wickman M, Wiercioch W, Yepes-Nuñez JJ, Zhang L, Zhang Y, Zidarn M, Zuberbier T, Schünemann HJ. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016
revision. J Allergy Clin Immunol. 2017; 140(4):950-958.
Bousquet J, Anto JM, Bachert C, Baiardini I, BosnicAnticevich S, Walter Canonica G, Melén E, Palomares O, Scadding GK, Togias A, Toppila-Salmi S. Allergic rhinitis. Nat Rev Dis Primers. 2020 Dec 3;6(1):95. Åberg N, Dahl Å, Benson MA. nasally applied cellulose powder in seasonal
allergic rhinitis (SAR) in children and adolescents; reduction of symptoms and relation to pollen load. Pediatr Allergy Immunol. 2011; 22(6):594–9.
Popov TA, Emberlin J, Josling P, Seifalian A. In vitro and in vivo Evaluation of the Efficacy and Safety of Powder Hydroxypropylmethylcellulose as Nasal Mucosal Barrier. Medical Devices: Eviden Res. 2020; 13:107–13. Product general information. Available from: https://www.nasaleze.
com/. Accessed 9-9-2021
Rowe RC, Shesky PJ, Quinn ME. (2009). Handbook of pharmaceutical excipients, Sixth edition, Pharmaceutical press, London.
George A Burdock. Safety assessment of hydroxypropyl methylcellulose as a food ingredient. Food and Chem Toxicol. 2007;(45):2341–51
Chen X, Guan W, Sun S, Zheng P, Sun L, Chen D, Douglas Zhang X. Effects of Intranasal Cellulose Powder on Asthma Control in Children with Mild-to-Moderate Perennial Allergic Rhinitis: A Randomized, Placebo-Controlled Trial. American J Rhinology & Allergy. 2019; Mar;33(2):184-193.
Bustamante-Marin XM, Ostrowski LE. Cilia and Mucociliary Clearance. Cold Spring Harb Perspect Biol. 2017; 9(4):a028241.
Ali ZA, Alkotaji M. Nose to brain delivery of drugs for CNS diseases Iraqi Journal of Pharmacy, 2021; 18(1):93-107.
Ali ZH and Alkotaji M. Smart hydrogel polymers for drug delivery. Military medical science letters. 2021; 90:1-14.
Ramadan AA, Elbakry AM, Esmaeil AH, Khaleel SA. Pharmaceutical and pharmacokinetic evaluation of novel rectal mucoadhesive hydrogels containing tolmetin sodium. J Pharm Investig. 2018; 48(6):673-683.
Al-bazzaz FY and Al-kotaji M. Ophthalmic in-situ sustained gel of ciprofloxacin, preparation and evaluation study. Int J Appl Pharmaceut. 2018; 10(4):153.
Saito S, Ainai A, Suzuki T, Harada N, Ami Y, Yuki Y, Takeyama H, Kiyono H, Tsukada H, Hasegawa H. The effect of mucoadhesive excipient on the nasal retention time of and the antibody responses induced by an intranasal influenza vaccine. Vaccine. 2016; 34(9):1201-7.
Bagul U, Gujar K, Dhat S, Aphale S, Bhavsar M. In vitro study of mucoadhesive strength of polymers for mucoadhesive drug delivery systems. International Journal of Current Pharmaceutical Research. 2009; 1(1):43-5.
Majithiya RJ, Ghosh PK, Umrethia ML, Murthy RSR. Thermoreversible-mucoadhesive Gel for nasal delivery of sumatriptan. AAPS PharmSciTech. 2006; 7(3):E80–E86.
Bhalerao H, Koteshwara K, Chandran, S. Design, optimisation and evaluation of in situ gelling nanoemulsion formulations of brinzolamide. Drug Deliv. and Transl. Res. 2019; 9:7-9.
Gupta S. Carbopol/Chitosan Based pH Triggered In-situ Gelling System for Ocular Delivery of Timolol Maleate. Scientia Pharmaceutica. 2010; 78(4):959–76.
WU C, QI H, CHEN W, HUANG C, SU C, LI W, & HOU S. Preparation and Evaluation of a Carbopol®/HPMC-based Insitu Gelling Ophthalmic System for Puerarin. YAKUGAKU ZASSHI. 2007; 127(1):183–191.
Magbool FF, Elnima EI, Shayoub ME, Hamedelniel EI. Design, Formulation, and Evaluation of Carbopol 940 and Xanthan Gum as Gel Bases for Oral Local Drug Delivery for Oral Mucosal Infectious Diseases. EJBPS. 2018; 5(10):9-21.
Bera K, Mazumder B, Khanam J. Study of the Mucoadhesive Potential of Carbopol Polymer in the Preparation of Microbeads Containing the Antidiabetic Drug Glipizide. AAPS PharmSciTech. 2015; 17(3):743–56.
Gadhave D, Rasal N, Sonawane R, Sekar M, Kokare C. Noseto-brain delivery of teriflunomide-loaded lipid-based carbopol-gellan gum nanogel for glioma: Pharmacological and in vitro cytotoxicity studies. Int J Biol Macromol. 2021; 167:906-20.
Shah R, Patel D, Mehta M, Patel C. Design and optimization of mucoadhesive nasal in-situ gel containing sodium cromoglycate using factorial design. Asian J Pharmaceut. 2011; 5(2):65.
Tyagi S, Sharma N, Gupta SK, Sharma A, Bhatnagar A, Kumar N, Kulkarni GT. (2015). Development and gamma scintigraphical clearance study of novel Hibiscus rosasinensis polysaccharide based mucoadhesive nasal gel of rizatriptan benzoate. J Drug Delivery Sci Technol 2015; 30:100–106.
Macias-Valle L, Finkelstein-Kulka A, Manji J, Okpaleke C, Al-Salihi S, Javer AR. Evaluation of sheep sinonasal endoscopic anatomy as a model for rhinologic research. World J Otorhinolaryngol - Head and Neck Surgery. (2018) Dec; 4(4): 268–272
Zaki NM, Awad GA, Mortada ND, Abd ElHady SS. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. EJBPS. 2007 32(4-5):296–307.
Alkufi HK and Kassab HJ. Formulation and Evaluation of Sustained Release Sumatriptan Mucoadhesive Intranasal insitu gel. Iraqi J Pharmaceut Sci. 2019; 28(2):95-104.